This clinic is part of the Clinical Neuroscience Research Unit at CMHC and runs trials and conducts other research into investigational treatments for depression and genetics of mood disorders. Residents have carried patients within this clinic both for medication and psychotherapeutic treatment and have participated as investigators in research studies.
The Yale Mood Disorders Research Program (MDRP) is dedicated to understanding the science of mood disorders, such as bipolar disorder (manic-depressive illness), depression and other mood disorders. Residents can participate in a multi-disciplinary group of scientists studying the genetic and environmental factors that contribute to mood disorders, and how these factors interact to affect the brain and cause the specific symptoms associated with these disorders.
This clinic is part of the Clinical Neuroscience Research Unit at CMHC. The clinic is involved in the evaluation and treatment of individuals with obsessive compulsive disorder. The clinic’s current research interests are largely focused on the use of glutamate-modulating drugs in the treatment of refractory OCD. Trainees are taught to complete evaluations of OCD patients presenting to the clinic for consultation or participation in research protocols. Trainees also carry a small number of their own psychotherapy and/or medication management patients in the clinic. Cognitive behavioral therapy is a mainstay of OCD treatment, and trainees who are interested in taking on CBT patients are also provided with CBT supervision.
PRIME Clinic (Prevention through Risk Identification, Management & Education)
PRIME aims to identify and monitor signs of risk for psychotic illness, reduce symptoms of mental and emotional difficulties, and better understand the development of pre-psychotic illness through clinical evaluations, diagnostic clarification, clinical consultation, follow-along monitoring, clinical trials, neuropsychological testing, neurological evaluations, and community education. Resident trainees have an opportunity to be involved in all aspects of this clinic and may carry their own patients as they are monitored for worsening of their presenting symptoms.
STEP Clinic (Early Psychosis)
This clinic is also part of the research program at the CMHC. The STEP clinic aims to study the natural course of disease among individuals presenting with first episode psychosis, as well as the effects of medication therapy and intensive service interventions. Individuals presenting to the STEP clinic come from a range of backgrounds and include a variety of clinical diagnoses (schizophreniform, bipolar, brief psychotic episode). Trainees working in the STEP Clinic have the opportunity to serve as the primary clinician for one or two patients, and engage in both medication management and therapy. Trainees also attend weekly team meetings (Fridays at 9am), and are encouraged to participate in the patient’s weekly group CBT session, which tends to be a highlight for patients and team leaders alike.
Transcranial Magnetic Stimulation
This is a program using rTMS as an investigational treatment for patients who have auditory hallucinations. Residents can become involved in assessing patients who present for this treatment and administering treatment within the blind and open stages of investigational treatment.